Nimbus Therapeutics presents clinical data from Ph1 study of oral allosteric TYK2 inhibitor at AAD Annual Meeting Clinical Impact Mar 25 Written By Frances Benson https://www.nimbustx.com/2022/03/25/nimbus-therapeutics-presents-clinical-data-from-phase-1b-study-of-oral-allosteric-tyk2-inhibitor-at-aad-annual-meeting/ 2022 Frances Benson
Nimbus Therapeutics presents clinical data from Ph1 study of oral allosteric TYK2 inhibitor at AAD Annual Meeting Clinical Impact Mar 25 Written By Frances Benson https://www.nimbustx.com/2022/03/25/nimbus-therapeutics-presents-clinical-data-from-phase-1b-study-of-oral-allosteric-tyk2-inhibitor-at-aad-annual-meeting/ 2022 Frances Benson
